TY - JOUR
T1 - Race Distribution in Nonarteritic Anterior Ischemic Optic Neuropathy
AU - Banc, Ana
AU - Kupersmith, Mark
AU - Newman, Nancy J.
AU - Biousse, Valérie
N1 - Funding Information:
Funding/Support: This study received no funding. Financial Disclosures: M.K.: The New York Eye and Ear Infirmary Foundation, New York, NY; Alfiero & Lucia Palestroni Foundation, Inc, Englewood Cliffs, NJ; NEI EY032522; Research to Prevent Blindness, Inc, New York, NY, unrestricted grant to the Department of Ophthalmology. N.J.N.: consultant for GenSight Biologics (Paris, France) and Neurophoenix (Paris, France), Santhera/Chiesi Pharmaceuticals (Pratteln, Switzerland), Stoke Therapeutics (Bedford, MA), and Avidity Biosciences (La Jolla, CA); supported in part by the National Institutes of Health's National Eye Institute core grant P30-EY06360 (Department of Ophthalmology, Emory University School of Medicine, Atlanta, GA) and by a departmental grant from Research to Prevent Blindness (New York, NY). V.B.: consultant for GenSight Biologics (Paris, France) and Neurophoenix (Paris, France); supported in part by the National Institutes of Health's National Eye Institute core grant P30-EY06360 (Department of Ophthalmology, Emory University School of Medicine, Atlanta, GA) and by a departmental grant from Research to Prevent Blindness (New York, NY). A.B.: no financial disclosures. All authors attest that they meet the current ICMJE criteria for authorship. Author Contributions: Data curation, Investigation, Formal analysis, Writing – original draft: A.B.; Conceptualization, Data curation, Investigation, Methodology, Writing – review and editing: M.K.; Conceptualization, Methodology, Validation, and Writing – review and editing: N.J.N.; Conceptualization, Methodology, Project administration, Supervision, Validation, and Writing – review and editing: V.B.
Publisher Copyright:
© 2023 Elsevier Inc.
PY - 2023/9
Y1 - 2023/9
N2 - Purpose: To describe the racial distribution of patients diagnosed with nonarteritic anterior ischemic optic neuropathy (NAION) in 2 large urban academic centers in the United States. Design: Retrospective cross-sectional study. Methods: All patients with NAION evaluated between 2014 and 2022 in tertiary neuro-ophthalmology services in Atlanta, GA, and New York, NY, respectively, were included. In order to assess the racial accessibility to our services, similar numbers of patients with idiopathic intracranial hypertension seen in the same services were included. Self-reported race at the time of neuro-ophthalmologic examination was collected for all patients. Results were compared with data published by the US Bureau of Census for Decennial Census in 2020 for the states of Georgia and New York, and for the total population of the United States. Results: In both locations, the vast majority of patients with NAION reported being White (91.06% in Atlanta and 78.9% in New York). Only 7.27% of patients in Atlanta and 3% in New York reported being Black, and 1.24% of patients in Atlanta and 5.9% in New York reported being Asian. There were a much higher proportion of White people among NAION patients than in the group of patients with idiopathic intracranial hypertension and in each respective state and in the United States. Conclusions: Our results show that the majority of patients with NAION are White, followed by Black and Asian races, respectively, thus confirming the NAION race distribution reported by past clinical trials.
AB - Purpose: To describe the racial distribution of patients diagnosed with nonarteritic anterior ischemic optic neuropathy (NAION) in 2 large urban academic centers in the United States. Design: Retrospective cross-sectional study. Methods: All patients with NAION evaluated between 2014 and 2022 in tertiary neuro-ophthalmology services in Atlanta, GA, and New York, NY, respectively, were included. In order to assess the racial accessibility to our services, similar numbers of patients with idiopathic intracranial hypertension seen in the same services were included. Self-reported race at the time of neuro-ophthalmologic examination was collected for all patients. Results were compared with data published by the US Bureau of Census for Decennial Census in 2020 for the states of Georgia and New York, and for the total population of the United States. Results: In both locations, the vast majority of patients with NAION reported being White (91.06% in Atlanta and 78.9% in New York). Only 7.27% of patients in Atlanta and 3% in New York reported being Black, and 1.24% of patients in Atlanta and 5.9% in New York reported being Asian. There were a much higher proportion of White people among NAION patients than in the group of patients with idiopathic intracranial hypertension and in each respective state and in the United States. Conclusions: Our results show that the majority of patients with NAION are White, followed by Black and Asian races, respectively, thus confirming the NAION race distribution reported by past clinical trials.
UR - http://www.scopus.com/inward/record.url?scp=85162914119&partnerID=8YFLogxK
U2 - 10.1016/j.ajo.2023.03.013
DO - 10.1016/j.ajo.2023.03.013
M3 - Article
C2 - 36963603
AN - SCOPUS:85162914119
SN - 0002-9394
VL - 253
SP - 201
EP - 205
JO - American Journal of Ophthalmology
JF - American Journal of Ophthalmology
ER -